Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Anatomic Stage IV Breast Cancer AJCC v8|Chemotherapy-Induced Peripheral Neuropathy|Metastatic Breast Carcinoma
Interventions: DRUG: Paclitaxel|DRUG: Monosialotetrahexosylganglioside|OTHER: Questionnaire Administration|OTHER: Quality-of-life assessment|DRUG: Placebo Administration
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)